12:00 AM
 | 
Mar 22, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Cipro ciprofloxacin regulatory update

FDA granted Orphan Drug designation for Bayer's ciprofloxacin dry powder inhaler (DPI) for the management of pulmonary infection due to...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >